Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts

[bkoffman]

Hi,

We have been busy.

The CLL Society is proud to have taken a leadership role in producing Management of CLL Patients Early in the COVID-19 Pandemic: An International Survey of CLL Experts cllsociety.org/2020/05/cll-... published in the American Journal of Hematology.

In our ASH 2019 interview with Dr. John Pagel, cllsociety.org/2020/05/ash-... we learn that PI3 kinase inhibitors are potent medications that control CLL, but their widespread adoption has been slowed by their potential side effects. An alternative dosing schedule may help.

Find out how Dr. Koffman relied on the results of his post-CAR-T MRD testing in his treatment decision. Watch Dr. Koffman’s story here, cllsociety.org/2020/05/dr-b....

Now on-demand! Watch Just Diagnosed: What Do I Need to Know? Find out everything you need to know, from A – Z from Dr. Neil Kay of the Mayo Clinic for those newly diagnosed with CLL, including what to watch out for, the prognostic testing you need, and how to stay healthy. Watch now! cllsociety.org/2020/04/cll-...

Patricia Koffman (on behalf of Brian)

Co-founder and Communications Director

CLL Society Inc.

P.O. Box 1390

Claremont, CA 91711

cllsociety.org